Topical probiotics as a therapeutic alternative for chronic rhinosinusitis: A preclinical proof of concept

American Journal of Rhinology and Allergy

Volumn 30, Issue 6, 2016, Pages e202-e205

  Schwartz, Joseph S ^a   Peres, Adam G ^a   Endam, Leandra Mfuna ^b   Cousineau, Benoit ^a   Madrenas, Joaquin ^a   Desrosiers, Martin ^b,c  

^a MCGILL UNIVERSITY   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; INTERLEUKIN 10; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR;

CELL CULTURE; CHRONIC DISEASE; EPITHELIUM CELL; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MICROFLORA; MONONUCLEAR CELL; PRECLINICAL STUDY; PRIMARY CELL CULTURE; RHINITIS; SINUSITIS; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANTI-INFLAMMATORY AGENTS; CELLS, CULTURED; CHRONIC DISEASE; DRUG EVALUATION, PRECLINICAL; EPITHELIAL CELLS; HUMANS; INTERLEUKIN-10; LEUKOCYTES, MONONUCLEAR; MICROBIOTA; PRIMARY CELL CULTURE; PROBIOTICS; RHINITIS; SINUSITIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84995896938     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2016.30.4372     Document Type: Article

References (30)

1. Anand VK. Epidemiology and economic impact of rhinosinusitis. Ann Otol Rhinol Laryngol Suppl 193:3-5, 2004.
2. Bhattacharyya N. Incremental health care utilization and expenditures for chronic rhinosinusitis in the United States. Ann Otol Rhinol Laryngol 120:423-427, 2011.
3. Macdonald KI, McNally JD, and Massoud E. The health and resource utilization of Canadians with chronic rhinosinusitis. Laryngoscope 119:184-189, 2009.
4. Fokkens WJ, Lund VJ, Mullol J, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinol Suppl 2012:3 p preceding table of contents, 1-298, 2012.
5. Desrosiers M. Refractory chronic rhinosinusitis: Pathophysiology and management of chronic rhinosinusitis persisting after endoscopic sinus surgery. Curr Allergy Asthma Rep 4:200-207, 2004.
6. Valera FC, Scrideli C, Queinoz R, et al. NF-kappaB expression predicts clinical outcome for nasal polyposis. Rhinology 48:408-441, 2010.
7. Di Giacinto C, Marinaro M, Sanchez M, et al. Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells. J Immunol 174:3237-3246, 2005.
8. Habermann W, Zimmermann K, Skarabis H, et al. Reduction of acute recurrence in patients with chronic recurrent hypertrophic sinusitis by treatment with a bacterial immunostimulant (Enterococcus faecalis Bacteriae of human origin [in German with English abstract]. Arzneimittelforschung 52:622-627, 2002.
9. Belkaid Y, and Naik S. Compartmentalized and systemic control of tissue immunity by commensals. Nat Immunol 14:646-653, 2013.
10. Chau TA, McCully ML, Brintnell W, et al. Toll-like receptor 2 ligands on the staphylococcal cell wall downregulate superantigen-induced T cell activation and prevent toxic shock syndrome. Nat Med 15:641-648, 2009.
11. Frodermann V, Chau TA, Sayedyahossein S, et al. A modulatory interleukin-10 response to staphylococcal peptidoglycan prevents Th1/Th17 adaptive immunity to Staphylococcus aureus. J Infect Dis 204:253-262, 2011.
12. Beebe AM, Cua DJ, and de Waal Malefyt R. The role of interleukin-10 in autoimmune disease: Systemic lupus erythematosus (SLE) and multiple sclerosis (MS). Cytokine Growth Factor Rev 13:403-412, 2002.
13. Salminen S, Bouley C, Boutron-Ruault MC, et al. Functional food science and gastrointestinal physiology and function. Br J Nutr 80(suppl. 1):S147-S171, 1998.
14. Isolauri E, Sutas Y, Kankaanpaa P, et al. Probiotics: Effects on immunity. Am J Clin Nutr 73(suppl.):444S-450S, 2001.
15. Pessi T, Sutas Y, Hurme M, and Isolauri E. Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin Exp Allergy 30:1804-1808, 2000.
16. Kotlarz D, Beier R, Murugan D, et al. Loss of interleukin-10 signaling and infantile inflammatory bowel disease: Implications for diagnosis and therapy. Gastroenterology 143:347-355, 2012.
17. Bahey-El-Din M, and Gahan CG. Lactococcus lactis: From the dairy industry to antigen and therapeutic protein delivery. Discov Med 9:455-461, 2010.
18. Braat H, Peppelenbosch MP, and Hommes DW. Interleukin-10-based therapy for inflammatory bowel disease. Expert Opin Biol Ther 3:725-731, 2003.
19. Mukerji SS, Pynnonen MA, Kim HM, et al. Probiotics as adjunctive treatment for chronic rhinosinusitis: A randomized controlled trial. Otolaryngol Head Neck Surg 140:202-208, 2009.
20. Kitz R, Martens U, Ziesenik E, et al. Probiotic E. faecalis: Adjuvant therapy in children with recurrent rhinosinusitis. Central Eur J Med 7:362-365, 2012.
21. Bendouah Z, Barbeau J, Hamad WA, and Desrosiers M. Biofilm formation by Staphylococcus aureus and Pseudomonas aeruginosa is associated with an unfavorable evolution after surgery for chronic sinusitis and nasal polyposis. Otolaryngol Head Neck Surg 134:991-996, 2006.
22. Peres AG, Stegen C, Li J, et al. Uncoupling of pro-And anti-inflammatory properties of Staphylococcus aureus. Infect Immun 83:1587-1597, 2015.
23. Dejima K, Randell SH, Stutts MJ, et al. Potential role of abnormal ion transport in the pathogenesis of chronic sinusitis. Arch Otolaryngol Head Neck Surg 132:1352-1362, 2006.
24. Benninger MS, Ferguson BJ, Hadley JA, et al. Adult chronic rhinosinusitis: Definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol Head Neck Surg 129(suppl.):S1-S32, 2003.
25. Peres AG, Stegen C, Li J, et al. Uncoupling of pro-And anti-inflammatory properties of Staphylococcus aureus. Infect Immun 83:1587-1597, 2015.
26. Boase S, Foreman A, Cleland E, et al. The microbiome of chronic rhinosinusitis: Culture, molecular diagnostics and biofilm detection. BMC Infect Dis 13:210, 2013.
27. Abreu NA, Nagalingam NA, Song Y, et al. Sinus microbiome diversity depletion and Corynebacterium tuberculostearicum enrichment mediates rhinosinusitis. Sci Transl Med 4:151ra124, 2012.
28. Aurora R, Chatterjee D, Hentzleman J, et al. Contrasting the microbiomes from healthy volunteers and patients with chronic rhinosinusitis. JAMA Otolaryngol Head Neck Surg 139:1328-1338, 2013.
29. Carney AS. Editorial: The microbiome of the sinuses and its relevance in health and disease. Am J Rhinol Allergy 30:1-2, 2016.
30. Anderson M, Stokken J, Sanford T, et al. A systematic review of the sinonasal microbiome in chronic rhinosinusitis. Am J Rhinol Allergy 30:161-166, 2016.